Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER)
Aalis provides the Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) with comprehensive Acquisition support services. This includes assistance with acquisition planning, contract administration, and procurement compliance to ensure efficient and transparent processes. In addition, Aalis contributes Financial and Program Management expertise, supporting budget analysis, reporting, and coordinated project oversight to advance CBER’s mission objectives effectively.